570 000 122 recepcja_cmbb@op.pl

Non-invasive prenatal examination does not require a surgical procedure and is safe for the mother and her child.

The key issue in non-invasive prenatal tests is ultrasound performed in a pregnant woman between 11 and 13 + 6 weeks of pregnancy together with the assessment of pregnant PAPP-A protein and the hormone – free B-HCG subunit. This study allows the child to assess the risk of the most common genetic abnormalities in a child – Down syndrome, Edwards syndrome, Patau syndrome or neural tube defects. In addition, the study allows you to assess the risk of premature delivery, intrauterine fetal growth inhibition or the risk of a dangerous pregnancy complication – eclampsia. If you are at increased risk of these diseases, you can start treatment.

During the prenatal visit, in addition to an ultrasound with cervical translucency (NT), nasal bone (NB), tricuspid valve flow, venous flow and uterine artery flow, a medical history will be collected and blood will be collected. At the end of the visit, the preliminary test results will be presented, and the final ones after receiving the blood test results.